← Back to Search

Behavioral Intervention

eMotion for Emotional Well-being

N/A

Recruiting

Led By Kelly L Wierenga, PhD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Has at least mild symptoms of depression (determined by Patient Health Questionnaire-8 [PHQ-8] scores of 5 or greater) and/or at least mild symptoms of anxiety (determined by the General Anxiety Disorder [GAD-7] scores of 5 or greater).

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test an intervention called eMotion that helps women from diverse backgrounds with emotion regulation skills. The intervention was revised to better suit the needs of these women who are more affected by social determin

Who is the study for?

This trial is for women living independently with mild symptoms of depression or anxiety, as measured by specific questionnaires. They must have experienced their first major cardiac event. The study aims to help those particularly affected by social factors that influence health recovery.

What is being tested?

The eMotion intervention is being tested for its relevance and effectiveness in helping women from diverse backgrounds manage emotions after a cardiovascular event. It's based on evidence-based emotion regulation skills tailored to meet unique needs.

What are the potential side effects?

Since eMotion is an emotion regulation training program rather than a drug, it may not have typical medical side effects but could potentially cause emotional discomfort or distress during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have mild depression or anxiety based on PHQ-8 or GAD-7 scores.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three months

This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Distress-Depression and Anxiety Stress Scale

Secondary study objectives

Physical Activity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: eMotion InterventionExperimental Treatment1 Intervention

This is a single-group study assessing participation satisfaction with the 10-week eMotion intervention. The eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for adults following a first cardiac event.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

eMotion

2016

N/A

~110

0 / 1Eligibility criteria met